Tranexamic acid

Tranexamic acid

Tranexamic acid is useful in a wide range of haemorrhagic conditions. The drug reduces postoperative blood losses and transfusion requirements in a number of types of surgery, with potential cost and tolerability advantages over aprotinin, and appears to reduce rates of mortality and urgent surgery in patients with upper gastrointestinal haemorrhage. Tranexamic acid reduces menstrual blood loss and is a possible alternative to surgery in menorrhagia, and has been used successfully to control bleeding in pregnancy.

Product name: Tranexamic acid

CAS No.: 1197-18-8

Assay: 99.0%~101.0%

Appearance: White or almost white, crystalline powder

Solubility: Freely soluble in water and in glacial acetic acid, practically insoluble in acetone and 96% alcohol

Clarity and color: Solution should clarify and colorless

Ph: 7.0-8.0

Loss on drying: ≤0.5%

Sulphated ash: ≤0.1%

Standard: BP

Packing: 25kgs/Drum

Storage:Store in cool & dry place. Keep away from strong light and heat.

Stop the bleeding.

Increase the elasticity of human skin and keep it firm and smooth.

Significantly inhibit the formation of melanin.

Maintain skin acid-base balance.

Form a sustained-release drug delivery system to improve the absorption capacity of cosmetics to nutrients.

Enhance color fastness after dyeing hair.

In a report of 2954 cases, the main adverse reactions were: loss of appetite 0.61% (18 cases), nausea 0.41% (12 cases),
vomiting 0.20% (6 cases), heartburn 0.17% (5 cases), pruritus 0.07% (2 cases), rash 0.07% (2 cases), etc.